Mr. Anders Lundstrom served as Chief Executive Officer and President of Orexo AB from February 2011 until February 5, 2013. He has international experience in Research and Development, Sales and Marketing within the Pharmaceutical Industry at such companies as Biogen Idec, AstraZeneca, JanssenCilag and BristolMyers Squibb. He is Pharmacist by profession and holds a MS degree in Pharmacy.
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
-1.39% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Stockholm
